These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2391686)

  • 1. A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles.
    Yee YK; Bernstein PR; Adams EJ; Brown FJ; Cronk LA; Hebbel KC; Vacek EP; Krell RD; Snyder DW
    J Med Chem; 1990 Sep; 33(9):2437-51. PubMed ID: 2391686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure-activity relationships of 1,6-disubstituted indoles and indazoles.
    Brown FJ; Yee YK; Cronk LA; Hebbel KC; Krell RD; Snyder DW
    J Med Chem; 1990 Jun; 33(6):1771-81. PubMed ID: 2342071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates.
    Zhang HC; Derian CK; Andrade-Gordon P; Hoekstra WJ; McComsey DF; White KB; Poulter BL; Addo MF; Cheung WM; Damiano BP; Oksenberg D; Reynolds EE; Pandey A; Scarborough RM; Maryanoff BE
    J Med Chem; 2001 Mar; 44(7):1021-4. PubMed ID: 11297447
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and thromboxane A2 antagonistic activity of [[1-aryl(or benzyl)-1-(benzenesulfonamido)methyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Suzuki T; Kato K; Ohashi T; Yasuda S; Kato H; Ito Y
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):765-77. PubMed ID: 8681409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of a series of peptidoleukotriene antagonists: synthesis and structure/activity relationships of 1,3,5-substituted indoles and indazoles.
    Matassa VG; Maduskuie TP; Shapiro HS; Hesp B; Snyder DW; Aharony D; Krell RD; Keith RA
    J Med Chem; 1990 Jun; 33(6):1781-90. PubMed ID: 2342072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of [4-[1-(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives.
    Sakurai S; Ogawa N; Onogi Y; Takeshita M; Takahashi H; Ohashi T; Kato K; Yasuda S; Kato H
    Chem Pharm Bull (Tokyo); 1997 May; 45(5):849-62. PubMed ID: 9178522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivatives.
    Bermudez J; Fake CS; Joiner GF; Joiner KA; King FD; Miner WD; Sanger GJ
    J Med Chem; 1990 Jul; 33(7):1924-9. PubMed ID: 2362270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. VI. Indazole derivatives.
    Yamaguchi M; Maruyama N; Koga T; Kamei K; Akima M; Kuroki T; Hamana M; Ohi N
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):332-4. PubMed ID: 7728936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monofluoromethanesulfonanilides. A new series of bronchodilators.
    Banitt EH; Coyne WE; McGurran KT; Robertson JE
    J Med Chem; 1974 Jan; 17(1):116-20. PubMed ID: 4148420
    [No Abstract]   [Full Text] [Related]  

  • 10. Acidic furo[3,2-b]indoles. A new series of potent antiallergy agents.
    Unangst PC; Carethers ME; Webster K; Janik GM; Robichaud LJ
    J Med Chem; 1984 Dec; 27(12):1629-33. PubMed ID: 6150113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and antiinflammatory actions of 4,5,6,7-tetrahydroindazole-5-carboxylic acids.
    Nagakura M; Ota T; Shimidzu N; Kawamura K; Eto Y; Wada Y
    J Med Chem; 1979 Jan; 22(1):48-52. PubMed ID: 423183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene receptor antagonists. 1. Initial structure-activity relationships.
    Youssefyeh RD; Magnien E; Lee TD; Chan WK; Lin CJ; Galemmo RA; Johnson WH; Tan J; Campbell HF; Huang FC
    J Med Chem; 1990 Apr; 33(4):1186-94. PubMed ID: 2157009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel series of (2-quinolinylmethoxy)phenyl-containing compounds as high-affinity leukotriene D4 receptor antagonists. 2. Effects of an additional phenyl ring on receptor affinity.
    Huang FC; Galemmo RA; Johnson WH; Poli GB; Morrissette MM; Mencel JJ; Warus JD; Campbell HF; Nuss GW; Carnathan GW
    J Med Chem; 1990 Apr; 33(4):1194-200. PubMed ID: 2157010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure.
    Musser JH; Kreft AF; Bender RH; Kubrak DM; Carlson RP; Chang J; Hand JM
    J Med Chem; 1989 Jun; 32(6):1176-83. PubMed ID: 2498516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted 3-(phenylmethyl)-1H-indole-5-carboxamides and 1-(phenylmethyl)indole-6-carboxamides as potent, selective, orally active antagonists of the peptidoleukotrienes.
    Jacobs RT; Brown FJ; Cronk LA; Aharony D; Buckner CK; Kusner EJ; Kirkland KM; Neilson KL
    J Med Chem; 1993 Feb; 36(3):394-409. PubMed ID: 8381184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of ICI 198,615: a novel, potent and selective peptide leukotriene antagonist.
    Snyder DW; Giles RE; Keith RA; Yee YK; Krell RD
    J Pharmacol Exp Ther; 1987 Nov; 243(2):548-56. PubMed ID: 2824751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,3,6-trisubstituted indoles as peptidoleukotriene antagonists: benefits of a second, polar, pyrrole substituent.
    Brown FJ; Cronk LA; Aharony D; Snyder DW
    J Med Chem; 1992 Jun; 35(13):2419-39. PubMed ID: 1320123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and pharmacological activity of 2,3-dihydro-1H-pyrazolo-[1,2-a]indazolium derivatives].
    Fujimura Y; Shiraki Y; Nawata Y; Matsunaga I
    Yakugaku Zasshi; 1986 Nov; 106(11):1002-7. PubMed ID: 3559900
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential antitumor agents. I. Synthesis of pyrroloindazole derivatives related to the pyrroloindole moieties of the antitumor antibiotic CC-1065.
    Massa S; Stefancich G; Artico M; Corelli F; Silvestri R
    Farmaco Sci; 1987 Aug; 42(8):567-74. PubMed ID: 3666127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.
    Procopiou PA; Barrett JW; Barton NP; Begg M; Clapham D; Copley RC; Ford AJ; Graves RH; Hall DA; Hancock AP; Hill AP; Hobbs H; Hodgson ST; Jumeaux C; Lacroix YM; Miah AH; Morriss KM; Needham D; Sheriff EB; Slack RJ; Smith CE; Sollis SL; Staton H
    J Med Chem; 2013 Mar; 56(5):1946-60. PubMed ID: 23409871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.